DESCRIPTION: Diabetic nephropathy (DN) is one of the major microvascular complications of diabetes and the most common cause of end-stage renal disease (ESRD)1,2. Previously, diabetic kidney disease (DKD) was thought to be a unidirectional process that starts with microalbuminuria and leads to end-stage renal failure.
As the world becomes increasingly aware of the benefits of stem cell technologies, countries in Asia and Oceania are embracing the technology; along with the United States which has loosened some of the restrictions in recent years. Here in California, ten years has passed since voters approved Proposition 71, which created the $3 billion state taxpayer-funded California Institute for Regenerative Medicine. In Europe, under general directives of the European Community (EC), individual member countries have the right to choose to use stem cells on the grounds of medical and health benefits.
The ongoing discovery of disease-specific biomarkers is driving the demand for reliable antibodies to facilitate research in the biomedical field. Molecular biomarkers help to accelerate our understanding of the cellular and molecular mechanisms of diseases. Cell-specific biomarkers play an important role in disease diagnosis, monitoring, prognosis and therapy with the added potential to identify individuals susceptible to disease. Over the...